The Steering Committee
Alastair Carruthers, MD, FRCP(C)
You need to upgrade your Flash Player
|
You need to upgrade your Flash Player to view this content.
What's New
|
• Interactive case study on volumizing with dermal fillers available now!
Our newest case study, developed with Steering Committee Member Mark L. Jewell, MD, explores treatment options for the off-label use of dermal fillers for mid-face volumizing. Upon completion of the case study, posttest, and evaluation form, you'll receive 1.0 AMA PRA Category 1 Credit instantly!
|
|
|
• New CME Webinar!
Current Concepts in Facial Aesthetics: Consensus Recommendations for Botulinum Toxin Type A (BoNTA) and Hyaluronic Acid (HA) Fillers is a CME Webinar archive featuring Drs Steven Fagien, Steven Dayan, and Jessica Wu. Presentations focus on best practices for BoNTA and HA Fillers used alone and in combination for the upper, middle, and lower face.
|
|
|
• Ask The Expert
Steering Committee Member Sue Ellen Cox, MD, addresses questions regarding appropriate management of a widened nasal root area following administration of botulinum toxin type A (BoNTA), appropriate dosing to ensure long-lasting duration of BoNTA, treatment options for severe hyperhidrosis of the feet, and more!
|
|
|
• Updated Product Information page!
This comprehensive resource provides information on product indications and contraindications, and adverse events for botulinum toxins, dermal fillers, and topical creams used in aesthetic-enhancement procedures. Links to labeling information, US FDA advisories, and commentaries from our Steering Committee are also featured!
|
|
|
• Clinical Literature Overviews
Our latest current literature entries explore the use of calcium hydroxylapatite microspheres and poly-L-lactic acid for HIV-associated facial lipoatrophy, combination energy-based treatment for photodamaged skin, and energy-based devices to address solar lentigines. Also featured: Expert commentary from Steering Committee Member Sue Ellen Cox, MD.
|
Slides of the Month
In The News
Doctor Used Patients' Liposuctioned Fat As Car Fuel
Dec 29, 2008 -- A plastic surgeon who practised in Beverly Hills, California, is being accused of using human fat liposuctioned from former patients to fuel his car. According to Forbes.com, Alan Bittner allegedly collected the human fat and turned it into biodiesel for his own SUV and his girlfriend's car. He is being investigated by California's public health department.
|
Cancer Institute Of New Jersey Receives Nearly $768,000 To Investigate A New Therapeutic Path Against Melanoma
Dec 28, 2008 -- With 2,300 New Jersey residents diagnosed with melanoma this year, the Garden State ranks sixth in the nation in new cases of the disease, according to the American Cancer Society. It is that statistic on which a scientist at The Cancer Institute of New Jersey (CINJ) hopes to have impact, thanks to a $768,000 grant awarded by the American Cancer Society to study melanoma development. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
|
2009 Trends And Predictions From The Editors Of Consumer Guide To Plastic Surgery
Dec 28, 2008 -- The editors of Consumer Guide to Plastic Surgery have gazed into their crystal balls to see what nips and tucks Americans will be seeking in 2009. From how the economy will affect cosmetic surgery to which new products will come to market, here's what we will see more - or less - of in the coming year: Less is more in 2009. The economic recession will spur many consumers to re-evaluate their cosmetic surgery plans.
|
LATISSE? - New Prescription Product Increases Length, Thickness And Darkness Of Eyelashes
Dec 27, 2008 -- Allergan, Inc. (NYSE: AGN) today announced the U.S. Food and Drug Administration (FDA) has approved LATISSE? (bimatoprost ophthalmic solution) 0.03% as a novel treatment for hypotrichosis of the eyelashes. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes. LATISSE? is the first and only science-based treatment approved by the FDA to enhance eyelash prominence as measured by increases in length, thickness and darkness of eyelashes.
|
|
|
|
Login
Please enter both email and password to log in
Participate in our
Online polls
|
|